Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing Access Your Profit Alerts

Biogen Inc Cmn (NASDAQ: BIIB)

$271.21 USD -$5.36 (-1.94%)
Last Price $271.21
Net Change $-5.36 (-1.94%)
Bid $0
Ask Price $0
Open Price $277.09
Previous Close Price $276.57
High Price $277.28
Low Price $271.06
Number of Trades 11,013
Volume 1,803,300
Fifty Two Week High $307.33 (2016-08-02)
Fifty Two Week Low $205.43 (2016-06-27)
Average Daily Volume 1,705,254
Share Outstanding 212,120 Shares
Total Dividend Payout 0/yr
Dividend Yield 0%
1st Quarter Earnings $5.2 (2017-04-25)
2nd Quarter Earnings $4.64 (2017-01-26)
3nd Quarter Earnings $4.78 (2016-10-26)
4th Quarter Earnings $4.8 (2016-07-21)
PE Ratio $13.4
EPS Growth $3.63
Recent Earnings $5.2
Annual EPS $20.23
Last Quarter EPS $
Market Capitalization $57.53B
Insider Shareholders % 0.0032%
Annual Revenue $0B
No. Shares Outstanding 212,120
Inst. Shareholder % 87.76%
Annual Net Income $0B
TTM Net Profit Margin $569.08
1-Year Return 7.07%
3-Year Return 2.55%
5-Year Return 119.71%
5-Year Revenue Growth 126.77%
5-Year Earnings Growth 246.23%
5-Year Dividend Growth 0%
Annual Dividend $0
Annual Dividend Yield 0%
Change in EPS YTD 3.63%
Dividends per Share $
Stock Split Ratio 900-829
Beta 0.79
Biogen is a leading biopharmaceutical company engaged in the research, development and marketing of targeted therapies for the treatment of cancer, autoimmune and inflammatory diseases. The company owns industry leading brands for the treatment of multiple sclerosis, next-generation treatments for hemophilia, and a deep clinical pipeline ranging from Alzheimer's disease, lupus nephritis to neuropathic pain.